Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2017-05-01
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The alternative treatment option is renal sympathetic denervation using catheter ablation. This new treatment method is not yet used in the standard care. Currently, studies are being conducted in specific centers to demonstrate the efficacy of this treatment.
Questionnaires are used to determine the preference of patients for one or the other option of hypertension treatment. So far, there are no findings.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901
Sympathetic Activity and Renal Denervation
NCT01355055
Renal Denervation in Treatment Resistant Hypertension
NCT01687725
Renal Sympathetic Denervation in Mild Refractory Hypertension
NCT01656096
The Effect of Renal Denervation on Biological Variables
NCT01427049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treated Hypertension with one or more medications
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Preventive Medicine
UNKNOWN
Roland E. Schmieder
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roland E. Schmieder
Full Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Preventive Medicine
Nuremberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRC2017PPiB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.